Uteroplacental ischemia in early- and late-onset pre-eclampsia: A role for the fetus?

Ultrasound in Obstetrics and Gynecology

Volumn 40, Issue 4, 2012, Pages 373-382

  Espinoza, J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PLACENTA PROTEIN;

ARTICLE; BLOOD; DOPPLER FLOWMETRY; ECHOGRAPHY; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; ISCHEMIA; PATHOLOGY; PATHOPHYSIOLOGY; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY; SECOND TRIMESTER PREGNANCY; UTERUS DISEASE; VASCULARIZATION;

BIOLOGICAL MARKERS; FEMALE; FETUS; GESTATIONAL AGE; HUMANS; ISCHEMIA; PLACENTA DISEASES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, SECOND; ULTRASONOGRAPHY, DOPPLER; UTERINE DISEASES;

EID: 84866886524     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.12280     Document Type: Note

References (105)

1. Ogden HG, Hildebrand GJ, Page EW,. Rise in blood pressure during ischaemia of the gravid uterus. Proc Soc Exp Biol Med 1940; 43: 49-51.
2. Page EW,. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol 1939; 37: 291-293.
3. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA,. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658.
4. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA,. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006; 12: 642-649.
5. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA,; CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992-1005.
6. Page EW,. The effect of eclamptic blood upon the urinary output and blood pressure of human recipients. J Clin Invest 1938; 17: 207-218.
7. Redman CW, Sargent IL,. Latest advances in understanding preeclampsia. Science 2005; 308: 1592-1594.
8. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R,. Pre-eclampsia. Lancet 2010; 376: 631-644.
9. von Dadelszen P, Magee LA, Roberts JM,. Subclassification of preeclampsia. Hypertens Preg 2003; 22: 143-148.
10. Dekker GA, Sibai BM,. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998; 179: 1359-1375.
11. Crocker IP, Cooper S, Ong SC, Baker PN,. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol 2003; 162: 637-643.
12. Leung DN, Smith SC, To KF, Sahota DS, Baker PN,. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001; 184: 1249-1250.
13. Sargent IL, Germain SJ, Sacks GP, Kumar S, Redman CW,. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol 2003; 59: 153-160.
14. Chua S, Wilkins T, Sargent I, Redman C,. Trophoblast deportation in pre-eclamptic pregnancy. Br J Obstet Gynaecol 1991; 98: 973-979.
15. Espinoza J, Uckele JE, Starr RA, Seubert DE, Espinoza AF, Berry SM,. Angiogenic imbalances: the obstetric perspective. Am J Obstet Gynecol 2010; 203: 17-18.
16. Rajakumar A, Cerdeira AS, Rana S, Zsengeller Z, Edmunds L, Jeyabalan A, Hubel CA, Stillman IE, Parikh SM, Karumanchi SA,. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension 2012; 59: 256-264.
17. Hill AB,. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295-300.
18. Ramma W, Ahmed A,. Is inflammation the cause of pre-eclampsia? Biochem Soc Trans 2011; 39: 1619-1627.
19. Harrington K, Cooper D, Lees C, Hecher K, Campbell S,. Doppler ultrasound of the uterine arteries: the importance of bilateral notching in the prediction of pre-eclampsia, placental abruption or delivery of a small-for-gestational- age baby. Ultrasound Obstet Gynecol 1996; 7: 182-188.
20. Albaiges G, Missfelder-Lobos H, Lees C, Parra M, Nicolaides KH,. One-stage screening for pregnancy complications by color Doppler assessment of the uterine arteries at 23 weeks' gestation. Obstet Gynecol 2000; 96: 559-564.
21. Papageorghiou AT, Yu CK, Cicero S, Bower S, Nicolaides KH,. Second-trimester uterine artery Doppler screening in unselected populations: a review. J Matern Fetal Neonatal Med 2002; 12: 78-88.
22. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH,. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 441-449.
23. Campbell DM, MacGillivray I, Carr-Hill R,. Pre-eclampsia in second pregnancy. Br J Obstet Gynaecol 1985; 92: 131-140.
24. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R,. Risk factors and clinical manifestations of pre-eclampsia. BJOG 2000; 107: 1410-1416.
25. Ochi H, Suginami H, Matsubara K, Taniguchi H, Yano J, Matsuura S,. Micro-bead embolization of uterine spiral arteries and changes in uterine arterial flow velocity waveforms in the pregnant ewe. Ultrasound Obstet Gynecol 1995; 6: 272-276.
26. Ochi H, Matsubara K, Kusanagi Y, Taniguchi H, Ito M,. Significance of a diastolic notch in the uterine artery flow velocity waveform induced by uterine embolisation in the pregnant ewe. Br J Obstet Gynaecol 1998; 105: 1118-1121.
27. Bower S, Bewley S, Campbell S,. Improved prediction of preeclampsia by two-stage screening of uterine arteries using the early diastolic notch and color Doppler imaging. Obstet Gynecol 1993; 82: 78-83.
28. Campbell S,. The uteroplacental circulation-why computer modelling makes sense. Ultrasound Obstet Gynecol 1995; 6: 237-239.
29. Espinoza J, Kusanovic JP, Bahado-Singh R, Gervasi MT, Romero R, Lee W, Vaisbuch E, Mazaki-Tovi S, Mittal P, Gotsch F, Erez O, Gomez R, Yeo L, Hassan SS,. Should bilateral uterine artery notching be used in the risk assessment for preeclampsia, small-for-gestational-age, and gestational hypertension? J Ultrasound Med 2010; 29: 1103-1115.
30. Duckitt K, Harrington D,. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005; 330: 565.
31. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH,. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009; 53: 812-818.
32. Rasmussen S, Irgens LM,. Fetal growth and body proportion in preeclampsia. Obstet Gynecol 2003; 101: 575-583.
33. Aardema MW, Saro MC, Lander M, De Wolf BT, Oosterhof H, Aarnoudse JG,. Second trimester Doppler ultrasound screening of the uterine arteries differentiates between subsequent normal and poor outcomes of hypertensive pregnancy: two different pathophysiological entities? Clin Sci (Lond) 2004; 106: 377-382.
34. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R,. Preeclampsia and fetal growth. Obstet Gynecol 2000; 96: 950-955.
35. MacKay AP, Berg CJ, Atrash HK,. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97: 533-538.
36. Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B,. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 2003; 189: 1173-1177.
37. Ogge G, Chaiworapongsa T, Romero R, Hussein Y, Kusanovic JP, Yeo L, Kim CJ, Hassan SS,. Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia. J Perinat Med 2011; 39: 641-652.
38. Deter RL, Rossavik IK, Harrist RB,. Development of individual growth curve standards for estimated fetal weight: I. Weight estimation procedure. J Clin Ultrasound 1988; 16: 215-225.
39. Ott WJ,. Intrauterine growth retardation and preterm delivery. Am J Obstet Gynecol 1993; 168: 1710-1715.
40. Lampl M, Gotsch F, Kusanovic JP, Espinoza J, Goncalves L, Gomez R, Nien JK, Frongillo EA, Romero R,. Downward percentile crossing as an indicator of an adverse prenatal environment. Ann Hum Biol 2008; 35: 462-474.
41. Sibai BM, Stella CL,. Diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 2009; 200: 481-487.
42. Espinoza J, Romero R, Mee KY, Kusanovic JP, Hassan S, Erez O, Gotsch F, Than NG, Papp Z, Jai Kim C,. Normal and abnormal transformation of the spiral arteries during pregnancy. J Perinat Med 2006; 34: 447-458.
43. Pijnenborg R, Vercruysse L, Hanssens M,. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006; 27: 939-958.
44. Kuzmina IY, Hubina-Vakulik GI, Burton GJ,. Placental morphometry and Doppler flow velocimetry in cases of chronic human fetal hypoxia. Eur J Obstet Gynecol Reprod Biol 2005; 120: 139-145.
45. Prefumo F, Sebire NJ, Thilaganathan B,. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices. Hum Reprod 2004; 19: 206-209.
46. Olofsson P, Laurini RN, Marsal K,. A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertension and fetal growth retardation. Eur J Obstet Gynecol Reprod Biol 1993; 49: 161-168.
47. Voigt HJ, Becker V,. Doppler flow measurements and histomorphology of the placental bed in uteroplacental insufficiency. J Perinat Med 1992; 20: 139-147.
48. Lin S, Shimizu I, Suehara N, Nakayama M, Aono T,. Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed. Obstet Gynecol 1995; 85: 760-765.
49. Aardema MW, Oosterhof H, Timmer A, van Rooy I, Aarnoudse JG,. Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses. Placenta 2001; 22: 405-411.
50. Madazli R, Somunkiran A, Calay Z, Ilvan S, Aksu MF,. Histomorphology of the placenta and the placental bed of growth restricted foetuses and correlation with the Doppler velocimetries of the uterine and umbilical arteries. Placenta 2003; 24: 510-516.
51. Kim YM, Chaiworapongsa T, Gomez R, Bujold E, Yoon BH, Rotmensch S, Thaler HT, Romero R,. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002; 187: 1137-1142.
52. Avagliano L, Bulfamante GP, Morabito A, Marconi AM,. Abnormal spiral artery remodelling in the decidual segment during pregnancy: from histology to clinical correlation. J Clin Pathol 2011; 64: 1064-1068.
53. Papageorghiou AT, Yu CK, Nicolaides KH,. The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2004; 18: 383-396.
54. Parra M, Rodrigo R, Barja P, Bosco C, Fernández V, Muñoz H, Soto-Chacõn E,. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 2005; 193: 1486-1491.
55. Espinoza J,. Recent biomarkers for the identification of patients at risk for preeclampsia: the role of uteroplacental ischemia. Expert Opin Med Diagn 2012; 6: 109-120.
56. Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Goncalves LF, Medina L, Edwin S, Hassan S, Carstens M, Gonzalez R,. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007; 196: 326.e1-13.
57. Lunell NO, Nylund LE, Lewander R, Sarby B,. Uteroplacental blood flow in pre-eclampsia measurements with indium-113m and a computer-linked gamma camera. Clin Exp Hypertens B 1982; 1: 105-117.
58. Moore RJ, Ong SS, Tyler DJ, Duckett R, Baker PN, Dunn WR, Johnson IR, Gowland PA,. Spiral artery blood volume in normal pregnancies and those compromised by pre-eclampsia. NMR Biomed 2008; 21: 376-380.
59. Cavanagh D, Rao PS, Knuppel RA, Desai U, Balis JU,. Pregnancy-induced hypertension: development of a model in the pregnant primate (Papio anubis). Am J Obstet Gynecol 1985; 151: 987-999.
60. Combs CA, Katz MA, Kitzmiller JL, Brescia RJ,. Experimental preeclampsia produced by chronic constriction of the lower aorta: validation with longitudinal blood pressure measurements in conscious rhesus monkeys. Am J Obstet Gynecol 1993; 169: 215-223.
61. Makris A, Thornton C, Thompson J, Thomson S, Martin R, Ogle R, Waugh R, McKenzie P, Kirwan P, Hennessy A,. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int 2007; 71: 977-984.
62. Llinas MT, Alexander BT, Seedek M, Abram SR, Crell A, Granger JP,. Enhanced thromboxane synthesis during chronic reductions in uterine perfusion pressure in pregnant rats. Am J Hypertens 2002; 15: 793-797.
63. Granger JP, LaMarca BB, Cockrell K, Sedeek M, Balzi C, Chandler D, Bennett W,. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med 2006; 122: 383-392.
64. Sedeek M, Gilbert JS, LaMarca BB, Sholook M, Chandler DL, Wang Y, Granger JP,. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens 2008; 21: 1152-1156.
65. Gilbert J, Dukes M, Lamarca B, Cockrell K, Babcock S, Granger J,. Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats. Am J Hypertens 2007; 20: 686-691.
66. George EM, Cockrell K, Aranay M, Csongradi E, Stec DE, Granger JP,. Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension 2011; 57: 941-948.
67. Gilbert JS, Babcock SA, Granger JP,. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 2007; 50: 1142-1147.
68. Gilbert JS, Gilbert SA, Arany M, Granger JP,. Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 2009; 53: 399-403.
69. Nagamatsu T, Fujii T, Kusumi M, Zou L, Yamashita T, Osuga Y, Momoeda M, Kozuma S, Taketani Y,. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004; 145: 4838-4845.
70. Nevo O, Soleymanlou N, Wu Y, Xu J, Kingdom J, Many A, Zamudio S, Caniggia I,. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 2006; 291: R1085-R1093.
71. Chaiworapongsa T, Espinoza J, Gotsch F, Kim YM, Kim GJ, Goncalves LF, Edwin S, Kusanovic JP, Erez O, Than NG, Hassan SS, Romero R,. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med 2008; 21: 25-40.
72. Soto E, Romero R, Kusanovic JP, Ogge G, Hussein Y, Yeo L, Hassan SS, Kim CJ, Chaiworapongsa T,. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med 2012; 25: 498-507.
73. Howard RB, Hosokawa T, Maguire MH,. Hypoxia-induced fetoplacental vasoconstriction in perfused human placental cotyledons. Am J Obstet Gynecol 1987; 157: 1261-1266.
74. Alvarez H, Medrano CV, Sala MA, Benedetti WL,. Trophoblast development gradient and its relationship to placental hemodynamics. II. Study of fetal cotyledons from the toxemic placenta. Am J Obstet Gynecol 1972; 114: 873-878.
75. Rajakumar A, Whitelock KA, Weissfeld LA, Daftary AR, Markovic N, Conrad KP,. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia. Biol Reprod 2001; 64: 499-506.
76. Qian D, Lin HY, Wang HM, Zhang X, Liu DL, Li QL, Zhu C,. Normoxic induction of the hypoxic-inducible factor-1 alpha by interleukin-1 beta involves the extracellular signal-regulated kinase 1/2 pathway in normal human cytotrophoblast cells. Biol Reprod 2004; 70: 1822-1827.
77. Sharma S, Norris WE, Kalkunte S,. Beyond the threshold: an etiological bridge between hypoxia and immunity in preeclampsia. J Reprod Immunol 2010; 85: 112-116.
78. Heazell AE, Moll SJ, Jones CJ, Baker PN, Crocker IP,. Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species. Placenta 2007; 28:Suppl A: S33-S40.
79. Järvenpää J, Vuoristo JT, Ukkola O, Hirvikoski P, Savolainen ER, Raudaskoski T, Ryynänen M,. Cord compression may rapidly influence the expression of placental angiogenic genes in pre-eclampsia. Placenta 2008; 29: 436-438.
80. Robinson NJ, Wareing M, Hudson NK, Blankley RT, Baker PN, Aplin JD, Crocker IP,. Oxygen and the liberation of placental factors responsible for vascular compromise. Lab Invest 2008; 88: 293-305.
81. Kingdom JC, Kaufmann P,. Oxygen and placental vascular development. Adv Exp Med Biol 1999; 474: 259-275.
82. Kingdom JC, Kaufmann P,. Oxygen and placental villous development: origins of fetal hypoxia. Placenta 1997; 18: 613-621.
83. Lyall F, Young A, Boswell F, Kingdom JC, Greer IA,. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery. Placenta 1997; 18: 269-276.
84. Hung TH, Burton GJ,. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 2006; 45: 189-200.
85. Fukushima K, Murata M, Hachisuga M, Tsukimori K, Seki H, Takeda S, Asanoma K, Wake N,. Hypoxia inducible factor 1 alpha regulates matrigel-induced endovascular differentiation under normoxia in a human extravillous trophoblast cell line. Placenta 2008; 29: 324-331.
86. Ietta F, Wu Y, Winter J, Xu J, Wang J, Post M, Caniggia I,. Dynamic HIF1A regulation during human placental development. Biol Reprod 2006; 75: 112-121.
87. De Ponti C, Carini R, Alchera E, Nitti MP, Locati M, Albano E, Cairo G, Tacchini L,. Adenosine A2a receptor-mediated, normoxic induction of HIF-1 through PKC and PI-3K-dependent pathways in macrophages. J Leukoc Biol 2007; 82: 392-402.
88. Haeberle HA, Durrstein C, Rosenberger P, Hosakote YM, Kuhlicke J, Kempf VA, Garofalo RP, Eltzschig HK,. Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection. PLoS One 2008; 3: e3352.
89. Burton GJ, Woods AW, Jauniaux E, Kingdom JC,. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009; 30: 473-482.
90. McCarthy FP, Kingdom JC, Kenny LC, Walsh SK,. Animal models of preeclampsia; uses and limitations. Placenta 2011; 32: 413-419.
91. Cox B, Sharma P, Evangelou AI, Whiteley K, Ignatchenko V, Ignatchenko A, Baczyk D, Czikk M, Kingdom J, Rossant J, Gramolini AO, Adamson SL, Kislinger T,. Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia. Mol Cell Proteomics 2011; 10:M111.012526.
92. Espinoza J, Espinoza AF,. Pre-eclampsia: a maternal manifestation of a fetal adaptive response? Ultrasound Obstet Gynecol 2011; 38: 367-370.
93. Espinoza J, Espinoza AF, Power GG,. High fetal plasma adenosine concentration: a role for the fetus in preeclampsia? Am J Obstet Gynecol 2011; 205: 485.e24-27.
94. Slegel P, Kitagawa H, Maguire MH,. Determination of adenosine in fetal perfusates of human placental cotyledons using fluorescence derivatization and reversed-phase high-perfor- mance liquid chromatography. Anal Biochem 1988; 171: 124-134.
95. George EM, Cockrell K, Adair TH, Granger JP,. Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. Am J Physiol Regul Integr Comp Physiol 2010; 299: R1629-R1633.
96. Jank A, Kratzsch J, Stepan H,. Effect of terminated fetal circulation on maternal angiogenic factors in severe early preeclampsia. Hypertens Pregnancy 2012; 31: 201-206.
97. Koga K, Osuga Y, Tajima T, Hirota Y, Igarashi T, Fujii T, Yano T, Taketani Y,. Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole. Fertil Steril 2010; 94: 305-308.
98. Ostlund I, Haglund B, Hanson U,. Gestational diabetes and preeclampsia. Eur J Obstet Gynecol Reprod Biol 2004; 113: 12-16.
99. Yogev Y, Xenakis EM, Langer O,. The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol 2004; 191: 1655-1660.
100. Pathak S, Lees CC, Hackett G, Jessop F, Sebire NJ,. Frequency and clinical significance of placental histological lesions in an unselected population at or near term. Virchows Arch 2011; 459: 565-572.
101. Sibai B, Dekker G, Kupferminc M,. Pre-eclampsia. Lancet 2005; 365: 785-799.
102. Belfort MA, Anthony J, Saade GR,. Prevention of eclampsia. Semin Perinatol 1999; 23: 65-78.
103. Howick J, Glasziou P, Aronson JK,. The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute? J R Soc Med 2009; 102: 186-194.
104. Phillips CV, Goodman KJ,. Causal criteria and counterfactuals; nothing more (or less) than scientific common sense. Emerg Themes Epidemiol 2006; 3: 5.
105. Espinoza J,. The need to redefine preeclampsia. Expert Opin Med Diagn 2012; 6: 347-357.